Cite
Co-targeting of Bcl-2 and mTOR pathway triggers synergistic apoptosis in BH3 mimetics resistant acute lymphoblastic leukemia
MLA
Maria Rosaria Ricciardi, et al. Co-Targeting of Bcl-2 and MTOR Pathway Triggers Synergistic Apoptosis in BH3 Mimetics Resistant Acute Lymphoblastic Leukemia. Jan. 2015. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....fc53e3c0f0ad7d680eba470713fac381&authtype=sso&custid=ns315887.
APA
Maria Rosaria Ricciardi, Paola Bergamo, Alberto M. Martelli, Robin Foà, Roberto Licchetta, Cinzia Rinaldo, Stefano Iacovelli, James A. McCubrey, Matteo Allegretti, Michele Milella, Agostino Tafuri, Ann Zeuner, & Simone Mirabilii. (2015). Co-targeting of Bcl-2 and mTOR pathway triggers synergistic apoptosis in BH3 mimetics resistant acute lymphoblastic leukemia.
Chicago
Maria Rosaria Ricciardi, Paola Bergamo, Alberto M. Martelli, Robin Foà, Roberto Licchetta, Cinzia Rinaldo, Stefano Iacovelli, et al. 2015. “Co-Targeting of Bcl-2 and MTOR Pathway Triggers Synergistic Apoptosis in BH3 Mimetics Resistant Acute Lymphoblastic Leukemia,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....fc53e3c0f0ad7d680eba470713fac381&authtype=sso&custid=ns315887.